PR
ProQR Therapeutics
PRQR·NASDAQLeiden NLFounded 2012100 employees
Micro CapbiotechPublicOphthalmology
Platform: RNA Editing Ophth
Market Cap
$0.15B
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (PRQR)
Loading PRQR stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| PRQ-8250 | PRQ-8250 | Phase 2/3 | 1 | RET | CKDLN | ||
| PRQ-3485 | PRQ-3485 | NDA/BLA | 1 | JAK2 | Crohn's |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)